Breaking News

Cognizant to Buy Trizetto for About $2.7 Billion in Merger of Healthcare IT Providers
Tweet TWEET

Tecan Falls as Much as 14% in Zurich on Higher Cost From Project

Tecan Group AG (TECN), a Swiss maker of laboratory equipment, fell the most in seven years in Zurich trading after saying a project to develop a diagnostics instrument has been delayed, leading to higher costs.

Tecan slid 8.30 francs, or 12 percent, to 61.70 francs at 10:55 a.m. The stock declined as much as 14 percent, the biggest intraday drop since Sept. 23, 2004.

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.